Document:

EX-10.19

 Exhibit 10.19 

LUCIRA HEALTH, INC. 

January 18, 2021 
 Hansgregory Charles Hartmann 

 

	Re:	 Employment Agreement 

Dear Hans: 
 On behalf of LUCIRA
HEALTH, INC. (the “Company”), it is my pleasure to offer you the position of Chief Operating Officer. The terms of your new employment are set forth below in this employment agreement (the
“Agreement”). 
 1. EMPLOYMENT BY THE COMPANY. 

(a) Start Date and Position. Your employment with the Company will begin on January 18, 2021 or such date as otherwise
agreed to by you and the Company (such actual date your employment begins (the “Start Date”)). You will serve as the Company’s Chief Operating Officer. 

(b) Duties and Location. You will perform those duties and responsibilities as are customary for the position of Chief Operating
Officer and as may be directed by Chief Executive Officer, to whom you will report. Your primary office location will be the Company’s offices in Emeryville, California. Notwithstanding the foregoing, the Company reserves the right to
reasonably require you to perform your duties at places other than your primary office location from time to time, and to require reasonable business travel. Subject to the terms of this Agreement, the Company may modify your job title, duties, and
reporting relationship as it deems necessary and appropriate in light of the Company’s needs and interests from time to time. 

(c) Outside Activities. Throughout your employment with the Company, you may engage in civic and
not-for-profit activities so long as such activities do not interfere with the performance of your duties hereunder or present a conflict of interest with the Company.
During your employment by the Company, except on behalf of the Company, you will not directly or indirectly serve as an officer, director, stockholder, employee, partner, proprietor, investor, joint venturer, associate, representative or consultant
of any other person, corporation, firm, partnership or other entity whatsoever known by you to compete with the Company (or is planning or preparing to compete with the Company), anywhere in the world, in any line of business engaged in (or planned
to be engaged in) by the Company; provided, however, that you may purchase or otherwise acquire up to (but not more than) one percent (1%) of any class of securities of any enterprise (but without participating in the activities of such enterprise)
if such securities are listed on any national or regional securities exchange. 
 2. COMPENSATION AND
BENEFITS. 
 (a) Base Salary. You will be paid a base salary at the rate of no less than $440,000 per year
and may be increased based on the Board’s review which will be conducted at least annually; provided however, the base salary may be reduced below its then current amount when such reduction is applied uniformly to all of the Company’s
executive officers. Your base salary will be paid on the Company’s ordinary payroll cycle, less applicable payroll deductions and withholdings. As an exempt salaried employee, you will be required to work the Company’s normal business
hours, and such additional time as appropriate for your work assignments and position, and you will not be entitled to overtime compensation. 

(b) Signing Bonus. You will be paid a signing bonus of $13,500 gross amount by February 5, 2021. 

(c) Employee Benefits. As a regular full-time employee, you will be eligible to participate in the Company’s standard
employee benefits offered to executive level employees, as in effect from time to time and subject to the terms and conditions of the benefit plans and applicable Company policies. A full description of these benefits is available upon request.
Subject to the terms of this Agreement, the Company may change your benefits from time to time in its discretion. 

  
 1 

 (d) Annual Discretionary Bonus. You will also be eligible to earn an annual
discretionary bonus with a target amount equal to 40% of your annual base salary. The amount of this bonus will be determined in the sole discretion of the Company and based, in part, on your performance and the performance of the Company during the
calendar year, as well as any other criteria the Company deems relevant, as set forth in the Company’s Employee Cash Incentive Plan or any successor bonus program sponsored by the Company; provided that any annual discretionary bonus must be
paid no later than 2-1/2 months after the end of the Company’s fiscal year. 
 (e) IPO Option Grant. On the date of the
underwriting agreement between the Company and the underwriters managing the initial public offering of the Company’s common stock (the “IPO”), pursuant to which such stock is priced for the initial public offering (the “IPO
Date”), you will be granted an option to purchase shares of the Company’s Common Stock (the “Option”). The Option will have an exercise price equal to the per share price that the Company’s Common Stock is sold on the IPO
Date in its initial public offering. The Option will be for a number of shares of the Company’s Common Stock so that the Option will have a grant date fair value for financial accounting purposes equal to $1,792,000. The Option will be granted
pursuant to and subject to the terms of the Company’s 2021 Equity Incentive Plan (the “Plan”), which will automatically become effective on the IPO Date, and its standard form of Option Grant Notice and Stock Option Agreement. The
Option will vest subject to your continued services with the Company over a two-year period in twenty-four (24) equal monthly installments following your Start Date, in each case subject to your continued
services with the Company through the applicable vesting dates, provided that, the vesting and exercisability of the shares subject to the option will be accelerated in full upon a Change in Control (as defined in the Plan) if your Continuous
Service (as defined in the Plan) has not terminated as of immediately prior to such Change in Control. 
 (f) Officer Severance
Benefit Plan. You will be eligible to participate in the Company’s Officer Severance Benefit Plan (the “Severance Plan”) subject to the terms and conditions of the Severance Plan. A copy of the Severance Plan has been provided to
you concurrently with this Agreement. 
 (g) Expenses. The Company will reimburse you for reasonable travel, entertainment or
other expenses incurred by you in furtherance of or in connection with the performance of your duties hereunder, in accordance with the Company’s expense reimbursement policies and practices as in effect from time to time; provided that you
shall be entitled to reimbursement for the full cost of the lesser of any business or first-class flights of greater than 2-hours in duration. 

(h) Indemnification. The Company will indemnify you by having you enter into the Company’s standard form of indemnification
agreement that all executive officers and directors have signed to the fullest extent permitted under applicable law and the Company’s Certificate of Incorporation and bylaws, and will include you under the Company’s Directors &
Officer’s liability insurance. 
 3. CONFIDENTIAL INFORMATION. 

(a) Confidentiality Agreement. As a Company employee, you will be expected to abide by Company rules and policies including
those rules and policies regarding the protection of the Company’s confidential information. You will be subject to the terms of the attached Employee Confidential Information and Inventions Assignment Agreement, which prohibits unauthorized
use or disclosure of the Company’s proprietary information, among other obligations (the “Confidentiality Agreement”), and which is incorporated herein by reference. 

(b) Conflicting Obligations. By signing this Agreement, you are representing that you have full authority to accept this
position and perform the duties of the position without conflict with any other obligations and that you are not involved in any situation that might create, or appear to create, a conflict of interest with respect to your loyalty or duties to the
Company. You specifically warrant that you are not subject to an employment agreement or restrictive covenant preventing full performance of your duties to the Company. You agree not to bring to the Company or use in the performance of your
responsibilities at the Company any information, materials or documents of a former employer that are not generally available to the public, unless you have obtained express written authorization from the former employer for their possession and
use. You also agree to honor all obligations to former employers during your employment with the Company. 
 4. AT-WILL EMPLOYMENT RELATIONSHIP. Your employment relationship with the Company is at will. Accordingly, you may terminate your employment with the Company at any time
and for any reason whatsoever simply by notifying the Company; and the Company may terminate your employment at any time, with or without Cause or advance notice. If your employment is terminated by you or the Company for any reason, you agree to
resign from any position you hold on the Company’s Board of Directors (“Board”), to be effective no later than the date of your termination (or such other date as requested by the Board). 

  
 2 

 5. COMPLIANCE WITH OR EXEMPTION
FROM SECTION 409A. It is intended that the benefits set forth in this Agreement satisfy, to the greatest extent possible, the exemptions from the application of
Section 409A of the Internal Revenue Code of 1986, as amended, (the “Code”) (Section 409A, together with any state law of similar effect, “Section 409A”) provided under Treasury Regulations 1.409A-1(b)(4), 1.409A-1(b)(5) and 1.409A-1(b)(9). With respect to reimbursements or in-kind
benefits provided to you hereunder (or otherwise) that are not exempt from Section 409A, the following rules shall apply: (i) the amount of expenses eligible for reimbursement, or in-kind benefits
provided, during any one of your taxable years shall not affect the expenses eligible for reimbursement, or in-kind benefit to be provided in any other taxable year, (ii) in the case of any reimbursements
of eligible expenses, reimbursement shall be made on or before the last day of your taxable year following the taxable year in which the expense was incurred, (iii) the right to reimbursement or in-kind
benefits shall not be subject to liquidation or exchange for another benefit. In addition, if you are determined to be a “specified employee,” within the meaning of Section 409(a)(2)(B)(i), then to the extent necessary to avoid subjecting
you to the imposition of any additional tax under Section 409A of the Code, amounts that would otherwise be payable under this Agreement during the six-month period immediately following your “separation from service” will not be paid to
you during such period, but will instead be accumulated and paid to you (or, in the event of your death, to your estate) in a lump sum on the first business day following the earlier of (a) the date that is six (6) months and one day after your
separation from service or (b) your death. 
 6. DISPUTE RESOLUTION. 

(a) Arbitration Agreement. To ensure the rapid and economical resolution of disputes that may arise in connection with your
employment with the Company, you and the Company agree that any and all disputes, claims, or causes of action, in law or equity, including but not limited to statutory claims, arising from or relating to the enforcement, breach, performance, or
interpretation of this Agreement, your employment with the Company, or the termination of your employment, shall be resolved pursuant to the Federal Arbitration Act, 9 U.S.C. § 1-16, to the fullest extent
permitted by law, by final, binding and confidential arbitration conducted by JAMS, Inc. or its successor (“JAMS”), under JAMS’ then applicable rules and procedures for employment disputes before a single arbitrator (available upon
request and also currently available at http://www.jamsadr.com/rules-employment-arbitration/). You acknowledge that by agreeing to this arbitration procedure, both you and the Company waive the right to resolve any such dispute through a
trial by jury or judge or administrative proceeding. 
 (b) Individual Claims. All claims, disputes, or causes of action
under this section, whether by you or the Company, must be brought in an individual capacity, and shall not be brought as a plaintiff (or claimant) or class member in any purported class or representative proceeding, nor joined or consolidated with
the claims of any other person or entity. The arbitrator may not consolidate the claims of more than one person or entity, and may not preside over any form of representative or class proceeding. To the extent that the preceding sentences regarding
class claims or proceedings are found to violate applicable law or are otherwise found unenforceable, any claim(s) alleged or brought on behalf of a class shall proceed in a court of law rather than by arbitration. This paragraph shall not apply to
any action or claim that cannot be subject to mandatory arbitration as a matter of law, including, without limitation, claims brought pursuant to the California Private Attorneys General Act of 2004, as amended, the California Fair Employment and
Housing Act, as amended, and the California Labor Code, as amended, to the extent such claims are not permitted by applicable law to be submitted to mandatory arbitration and such applicable law(s) are not preempted by the Federal Arbitration Act or
otherwise invalid (collectively, the “Excluded Claims”). In the event you intend to bring multiple claims, including one of the Excluded Claims listed above, the Excluded Claims may be publicly filed with a court, while any other claims
will remain subject to mandatory arbitration. 
 (c) Process. You will have the right to be represented by legal counsel at
any arbitration proceeding. Questions of whether a claim is subject to arbitration under this agreement shall be decided by the arbitrator. Likewise, procedural questions which grow out of the dispute and bear on the final disposition are also
matters for the arbitrator. The arbitrator shall: (a) have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (b) issue a written statement
signed by the arbitrator regarding the disposition of each claim and the relief, if any, awarded as to each claim, the reasons for the award, and the arbitrator’s essential findings and conclusions on which the award is based. The arbitrator
shall be authorized to award all relief that you or the Company would be entitled to seek in a court of law. The Company shall pay all JAMS arbitration fees in excess of the administrative fees that you would be required to pay if the dispute were
decided in a court of law. 

  
 3 

 (d) Injunctive Relief. Nothing in this letter agreement is intended to prevent
either you or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration. Any awards or orders in such arbitrations may be entered and enforced as judgments in the federal and
state courts of any competent jurisdiction. 
 7. MISCELLANEOUS. This Agreement, together with your Confidentiality Agreement,
forms the complete and exclusive statement of your employment agreement with the Company. It supersedes any other agreements or promises made to you by anyone, whether oral or written. Changes in your employment terms, other than those changes
expressly reserved to the Company’s or the Board’s discretion in this Agreement, require a written modification approved by the Company and signed by a duly authorized officer of the Company (other than you). This Agreement will bind the
heirs, personal representatives, successors and assigns of both you and the Company, and inure to the benefit of both you and the Company, their heirs, successors and assigns. If any provision of this Agreement is determined to be invalid or
unenforceable, in whole or in part, this determination shall not affect any other provision of this Agreement and the provision in question shall be modified so as to be rendered enforceable in a manner consistent with the intent of the parties
insofar as possible under applicable law. This Agreement shall be construed and enforced in accordance with the laws of the State of California without regard to conflicts of law principles. Any ambiguity in this Agreement shall not be construed
against either party as the drafter. Any waiver of a breach of this Agreement, or rights hereunder, shall be in writing and shall not be deemed to be a waiver of any successive breach or rights hereunder. This Agreement may be delivered and executed
via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or other applicable law) or other transmission method and shall be deemed to have been
duly and validly delivered and executed and be valid and effective for all purposes. 
 Please sign and date this Agreement and return a
signed copy to me on January 18, 2021 to confirm your acceptance of this Agreement. 
  

							
	LUCIRA HEALTH, INC.	 		 		 	
				
	 /s/ Erik T. Engelson
	 		 		 	
	Erik T. Engelson	 		 		 	
	President and Chief Executive Officer	 		 		 	
				
	Accepted and Agreed:	 		 		 	
				
	 /s/ Hansgregory Charles Hartmann
	 		 	 January 26, 2021
	 	
	Hansgregory Charles Hartmann	 		 	Date	 	

  
 4Exhibit 10.1

 

LIMITED WAIVER AND CONSENT TO CREDIT
AGREEMENT

 

THIS LIMITED WAIVER
AND CONSENT TO CREDIT AGREEMENT (this “Waiver”) dated as of January 31, 2021 between SEQUENTIAL BRANDS GROUP,
INC., a Delaware corporation (the “Borrower”), the Guarantors party hereto, the Lenders party hereto, and WILMINGTON
TRUST, NATIONAL ASSOCIATION, as administrative agent and collateral agent (the “Agent”), in consideration of
the mutual covenants herein contained and benefits to be derived herefrom.

 

W
I T N E S S E T H:

 

WHEREAS, the Borrower,
the Guarantors, the Lenders and the Agent are party to that certain Third Amended and Restated Credit Agreement dated as of July
1, 2016 (as amended, restated, supplemented or modified and in effect as of the date hereof, the “Credit Agreement”);

 

WHEREAS, on November
15, 2020, the Borrower, the Agent, and Lenders constituting Required Lenders entered into the Fifth Amendment pursuant to which
(i) the parties thereto amended certain provisions of the Credit Agreement and (ii) the Required Lenders granted the Borrower the
Requested Waiver (as such term is defined in the Fifth Amendment) on the terms set forth in the Fifth Amendment in respect of the
Specified Events of Default (as such term is defined in the Fifth Amendment);

 

WHEREAS, on December
31, 2020, the Borrower, Lenders constituting Required Lenders and the Agent entered into that certain Limited Waiver and Consent
to Credit Agreement pursuant to which the Required Lenders extended the Requested Waiver to January 31, 2021, on the terms and
conditions set forth therein;

 

WHEREAS, the Borrower
has requested that the Lenders party hereto (constituting Required Lenders) and the Agent further extend the Requested Waiver to
February 21, 2021, on the terms and for the period set forth herein;

 

WHEREAS, the Required
Lenders and the Agent (at the direction of the Required Lenders) have agreed to extend the Requested Waiver as set forth herein.

 

NOW THEREFORE, in consideration
of the mutual promises and agreements herein contained, the parties hereto hereby agree as follows:

 

		1.	Incorporation of Terms. All capitalized terms
not otherwise defined herein shall have the same meaning as in the Credit Agreement.

 

		2.	Representations and Warranties. The Borrower hereby represents and warrants that (i) no
Default or Event of Default exists under the Credit Agreement or under any other Loan Document on and as of the date hereof (other
than the Specified Events of Default subject to the Requested Waiver), and (ii) after giving effect to this Waiver, all representations
and warranties contained in the Credit Agreement and the other Loan Documents are true and correct, in all material respects, on
and as of the date hereof, except (i) to the extent that such representations and warranties specifically refer to an earlier date,
in which case they shall be true and correct as of such earlier date, and (ii) in the case of any representation and warranty qualified
by materiality, they shall be true and correct in all respects.

 

[Signature Page to Limited Waiver and Consent]

 

     

     

    

 

		3.	Limited Waiver. Subject to the satisfaction of
the conditions precedent set forth in Section 4 of this Waiver, Agent and the Lenders party hereto hereby grant an extension to
the Requested Waiver through February 21, 2021 (subject to further extension as may be granted as set forth below); provided,
that the foregoing waiver shall be effective only to the extent specifically set forth herein and shall not (a) be construed as
a consent to or waiver of (i) any breach, Default or Event of Default other than as specifically waived herein, or (ii) any breach,
Default or Event of Default of which Agent or any of the Lenders have not been informed by any Loan Party, (b) affect the right
of Agent or any of the Lenders to demand strict compliance by each Loan Party with all terms and conditions of the Credit Agreement
and the Loan Documents, except as specifically consented to, modified or waived by the terms hereof, (c) be deemed a consent to
or waiver of any future transaction or action on the part of any Loan Party requiring the Lenders’ or the Required Lenders’
consent or approval under the Credit Agreement or the Loan Documents, or (d) diminish, prejudice or waive any of Agent’s
or any Lender’s rights and remedies under the Credit Agreement, any of the other Loan Documents, or applicable law, whether
arising as a consequence of any Default or Event of Default which may now exist or otherwise, and Agent and each of the Lenders
hereby reserve all of such rights and remedies. It is understood and agreed that the Requested Waiver is temporary and shall expire
on February 21, 2021 unless further extended by the Agent (at the direction of the Required Lenders in their sole discretion).
Upon the expiration of the Requested Waiver, the Specified Events of Defaults shall constitute an immediate Event of Default under
the Credit Agreement. For the avoidance of doubt and notwithstanding anything herein to the contrary, during the period in which
the Requested Waiver is in effect, to the extent any provision of the Credit Agreement or any other Loan Document is qualified
by, or requires the absence of, any Default or Event of Default, a Default or Event of Default shall be deemed to have occurred
for purposes of such provisions as a result of the Specified Events of Default notwithstanding the Requested Waiver.

 

		4.	Conditions to Effectiveness. This Waiver shall
not be effective until each of the following conditions precedent has been fulfilled to the satisfaction of the Agent (at the
direction of the Required Lenders):

 

		a.	This Waiver shall have been duly executed and delivered by the Borrower, the other Loan Parties,
the Agent, and the Required Lenders, and the Agent shall have received evidence thereof.

 

		b.	The Agent shall have received a duly executed and effective Amendment to Fourth Amendment to Third
Amended and Restated Credit Agreement Side Letter, dated as of the date hereof, by and among the Borrower, the Agent and the Lenders
party thereto (the “Side Letter Amendment”).

 

		c.	The Borrower shall deliver to the KKR Representative a duly executed copy of the Stifel Engagement Letter (as defined in the
Side Letter Amendment).

 

		d.	All action on the part of the Borrower and the other Loan Parties necessary for the valid execution,
delivery and performance by the Borrower and the other Loan Parties of this Waiver and the other Loan Documents shall have been
duly and effectively taken.

 

[Signature Page to Limited Waiver and Consent]

 

     

     

    

 

		e.	After giving effect to this Waiver, no Default or Event of Default shall have occurred and be continuing.

 

		f.	The Borrower shall have paid in full all fees and expenses of the Agent (including the reasonable
and documented fees and expenses of counsel for the Agent) and the KKR Representative (including those of King & Spalding LLP
and Province Inc.) due and payable on or prior to the date hereof, and in the case of expenses, to the extent invoiced at least
one (1) Business Day prior to the date hereof.

 

		5.	Binding Effect. The terms and provisions hereof
shall be binding upon and inure to the benefit of the parties hereto and their heirs, representatives, successors and assigns.

 

		6.	Reaffirmation of Obligations. The Borrower and each Guarantor hereby ratifies the Loan Documents
and acknowledges and reaffirms (a) that it is bound by all terms of the Loan Documents applicable to it and (b) that
it is responsible for the observance and full performance of its respective Obligations.

 

		7.	Loan Document. This Waiver shall constitute a Loan Document under the terms of the Credit
Agreement.

 

		8.	Multiple Counterparts. This Waiver may be executed
in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all
of which when taken together shall constitute a single contract. Delivery of an executed counterpart of a signature page of this
Waiver by telecopy, pdf or other electronic transmission shall be as effective as delivery of a manually executed counterpart
of this Waiver.

 

		9.	Governing Law. THIS WAIVER AND ANY CLAIMS, CONTROVERSY,
DISPUTE OR CAUSE OF ACTION, WHETHER IN LAW OR EQUITY, WHETHER IN CONTRACT OR IN TORT OR OTHERWISE BASED UPON, ARISING OUT OF OR
RELATING TO THIS WAIVER AND THE TRANSACTIONS CONTEMPLATED HEREBY SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW
OF THE STATE OF NEW YORK.

 

		10.	Consent to Jurisdiction; Service of Process; Waiver of Jury Trial. The jurisdiction, service
of process and waiver of jury trial provisions set forth in Sections 10.14 and 10.15 of the Credit Agreement are hereby incorporated
by reference, mutatis mutandis.

 

		11.	Agent Authorization. Each of the undersigned Lenders hereby authorizes and directs Agent
to execute and deliver this Waiver on its behalf and, by its execution below, each of the undersigned Lenders agrees to be bound
by the terms and conditions of this Waiver.

 

[Signature Page to Limited Waiver and Consent]

 

     

     

    

 

 IN WITNESS WHEREOF,
this Waiver has been duly executed and delivered by each of the parties hereto as of the date first above written.

 

   	 	BORROWER:
	 	 	 
	 	 	SEQUENTIAL BRANDS GROUP, INC.
	 	 	 
	 	 	By:  	/s/ William Sweedler
	 	 	Name:  William Sweedler
	 	 	Title:  Executive Chairman
	 	 	 
	 	 	 
	 	GUARANTORS:
	 	 	 
	 	 	SQBG, INC.
	 	 	 
	 	 	By:  	/s/ William Sweedler
	 	 	Name:  William Sweedler
	 	 	Title:  Executive Chairman
	 	 	 
	 	 	SEQUENTIAL LICENSING, INC.
	 	 	 
	 	 	By:  	/s/ William Sweedler
	 	 	Name:  William Sweedler
	 	 	Title:  Executive Chairman
	 	 	 
	 	 	WILLIAM RAST LICENSING, LLC
	 	 	 
	 	 	By:  	/s/ William Sweedler
	 	 	Name:  William Sweedler
	 	 	Title:  Executive Chairman
	 	 	 
	 	 	HEELING SPORTS LIMITED  
	 	 	 
	 	 	By:  	/s/ William Sweedler
	 	 	Name:  William Sweedler
	 	 	Title:  Executive Chairman

 

[Signature Page to Limited Waiver and Consent]

 

     

     

    

 

	 	 	B®AND MATTER, LLC
	 	 	 
	 	 	By: 	 /s/ William Sweedler
	 	 	Name:  William Sweedler
	 	 	Title:  Executive Chairman
	 	 	 
	 	 	SBG FM, LLC
	 	 	 
	 	 	By: 	 /s/ William Sweedler
	 	 	Name:  William Sweedler
	 	 	Title:  Executive Chairman
	 	 	 
	 	 	SBG UNIVERSE BRANDS, LLC
	 	 	 
	 	 	By:  	/s/ William Sweedler
	 	 	Name:  William Sweedler
	 	 	Title:  Executive Chairman
	 	 	 
	 	 	GALAXY BRANDS LLC
	 	 	 
	 	 	By:  	/s/ William Sweedler
	 	 	Name:  William Sweedler
	 	 	Title:  Executive Chairman
	 	 	 
	 	 	The Basketball Marketing Company, Inc. 
	 	 	 
	 	 	By:  	/s/ William Sweedler
	 	 	Name:  William Sweedler
	 	 	Title:  Executive Chairman
	 	 	 
	 	 	AMERICAN SPORTING GOODS CORPORATION
	 	 	 
	 	 	By: 	/s/
William Sweedler
	 	 	Name:  William Sweedler
	 	 	Title:  Executive Chairman
	 	 	 
	 	 	LNT BRANDS LLC 
	 	 	 
	 	 	By:  	/s/ William Sweedler
	 	 	Name:  William Sweedler
	 	 	Title:  Executive Chairman
	 	 	 
	 	 	JOE’S HOLDINGS LLC
	 	 	 
	 	 	By: 	 /s/ William Sweedler
	 	 	Name:  William Sweedler
	 	 	Title:  Executive Chairman
	 	 	 
	 	 	GAIAM BRAND HOLDCO, LLC
	 	 	 
	 	 	By: 	 /s/ William Sweedler
	 	 	Name:  William Sweedler
	 	 	Title:  Executive Chairman
	 	 	 
	 	 	GAIAM AMERICAS, INC.
	 	 	 
	 	 	By:  	/s/ William Sweedler
	 	 	Name:  William Sweedler
	 	 	Title:  Executive Chairman
	 	 	 
	 	 	SBG-GAIAM HOLDINGS, LLC
	 	 	 
	 	 	By: 	 /s/ William Sweedler
	 	 	Name:  William Sweedler
	 	 	Title:  Executive Chairman

 

[Signature Page to Limited Waiver and Consent]

 

     

     

    

 

	 	 	wilmington trust, national association, as Agent
	 	 	 
	 	 	By: 	 /s/ David Bergstrom
	 	 	Name:  David Bergstrom
	 	 	Title:  Vice President

 

[Signature Page to Limited Waiver and Consent]

 

     

     

    

  

 

	 	LENDERS:
	 	 
	 	 
	 	 	FS KKR CAPITAL CORP.
	 	 	 
	 	 	By:	/s/ Jessica Woolf
	 	 	Name: Jessica Woolf
	 	 	Title: Authorized Signatory
	 	 
	 	FS KKR MM CLO 1 LLC
	 	 
	 	By:	/s/ Jessica Woolf
	 	Name: Jessica Woolf
	 	Title: Authorized Signatory
	 	 
	 	 
	 	DARBY CREEK LLC
	 	 
	 	By:	/s/ Jessica Woolf
	 	Name: Jessica Woolf
	 	Title: Authorized Signatory
	 	 
	 	 
	 	FS KKR CAPITAL CORP. II
	 	 
	 	By:	/s/ Jessica Woolf
	 	Name: Jessica Woolf
	 	Title: Authorized Signatory
	 	 
	 	 
	 	DUNLAP FUNDING LLC
	 	 	 
	 	 	By:	/s/ Jessica Woolf
	 	 	Name: Jessica Woolf
	 	 	Title: Authorized Signatory

 

[Signature Page to Limited Waiver
and Consent]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}]]